1796 logo

GeneFerm Biotechnology Co., Ltd. Stock Price

TPEX:1796 Community·NT$2.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1796 Share Price Performance

NT$49.80
2.20 (4.62%)
NT$49.80
2.20 (4.62%)
Price NT$49.80

1796 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks
1 Reward

GeneFerm Biotechnology Co., Ltd. Key Details

NT$654.9m

Revenue

NT$491.7m

Cost of Revenue

NT$163.2m

Gross Profit

NT$147.2m

Other Expenses

NT$16.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.39
24.92%
2.45%
30.8%
View Full Analysis

About 1796

Founded
1999
Employees
n/a
CEO
Jinde Jin
WebsiteView website
www.geneferm.com

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company offers microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well as probiotics and peptide ingredients. It also provides private label supplements; and microbial fermentation toll manufacturing services. The company was founded in 1999 and is headquartered in Tainan City, Taiwan.

Recent 1796 News & Updates

Recent updates

No updates